Histamine intolerance: Many suspicions, little evidence

By

This published article highlights that food intolerance is a non-immunological adverse reaction to foods or food components that are normally well tolerated. Histamine intolerance (HIT) is a proposed form of food intolerance in which symptoms are thought to result from impaired histamine metabolism, excessive histamine exposure, or an imbalance between histamine intake and the body’s ability to break it down.

Although histamine intolerance likely exists in some individuals, it remains poorly understood and potentially overdiagnosed. Scientific evidence supporting many commonly held assumptions about HIT is still limited. Because symptoms can be diverse and overlap with allergies, gastrointestinal disorders, migraine, medication effects, and numerous other conditions, diagnosis requires careful evaluation and exclusion of alternative causes.

DAO and Genetic Analysis

Diamine oxidase (DAO) is one of the enzymes involved in histamine metabolism, particularly in the gastrointestinal tract. Genetic analysis may examine variants in the AOC1 gene, which encodes DAO, to identify a possible inherited predisposition to altered or reduced DAO expression or activity.

However, an AOC1 genetic variant does not by itself establish a diagnosis of histamine intolerance. Likewise, measurements of DAO activity or concentration in the blood currently lack sufficient reliability and standardization to serve as definitive diagnostic tests. Genetic and laboratory findings therefore need to be interpreted in the broader clinical context rather than used as stand-alone confirmation of HIT.

Histamine intolerance may also have indirect effects on processes involving the vascular, immune, or lymphatic systems, but there is currently no strong evidence demonstrating that HIT directly alters lymphatic fluid (chyle) composition or lymphatic flow.

Management

Management primarily focuses on identifying and reducing relevant dietary histamine exposure. A structured, temporary low-histamine diet followed by controlled reintroduction is generally more informative than relying indefinitely on highly restrictive food lists. DAO supplementation and, in selected cases, antihistamines may provide additional symptom relief, although responses vary and the supporting evidence remains limited.

Key Points

1. Histamine is a normal and essential part of the body

Histamine is an important signaling molecule involved in immune responses, gastrointestinal function, vascular regulation, and the nervous system. It is naturally produced by the body and is also present in foods, particularly aged, fermented, processed, or improperly stored products.

Histamine itself is therefore not inherently harmful. Problems are proposed to arise when histamine exposure exceeds an individual's capacity to metabolize it effectively.

2. Diagnosing histamine intolerance is difficult

There is currently no universally accepted laboratory test or validated biomarker that can reliably confirm histamine intolerance.

Blood DAO measurements and genetic testing, including analysis of AOC1 variants, are not sufficiently reliable to diagnose HIT on their own. Symptoms are also highly variable and overlap with many other conditions, including food allergy, gastrointestinal disorders such as irritable bowel syndrome, migraine, and other causes of histamine-related symptoms.

Consequently, clinical assessment generally involves:

  • ruling out other plausible diseases or causes of symptoms;

  • conducting a structured low-histamine dietary trial when appropriate;

  • monitoring whether symptoms improve;

  • and subsequently reintroducing histamine-containing foods to determine whether symptoms reproducibly return.

This elimination-and-rechallenge approach is currently more clinically meaningful than relying on a single blood or genetic test.

3. Histamine levels in food are unpredictable

Histamine content can vary substantially even between apparently identical foods. Levels are influenced by factors such as freshness, storage duration, storage temperature, fermentation, processing methods, and bacterial growth.

For this reason, rigid lists dividing foods into universally "safe" and "unsafe" categories can be misleading. Individual tolerance and food handling may be as important as the type of food itself.

4. Freshness and storage may matter more than cooking

Food handling is particularly relevant because histamine can accumulate during storage.

Vacuum sealing can slow microbial growth and histamine formation but does not necessarily prevent it. Freezing is generally much more effective at limiting further histamine formation.

Cooking, however, does not reliably eliminate histamine because histamine is relatively heat-stable. Therefore, cooking an already histamine-rich food does not necessarily make it suitable for someone who is sensitive to dietary histamine.

Fresh meat and fish generally have lower histamine levels than products that have been aged, fermented, processed, or stored for extended periods.

5. Eating at restaurants can be challenging

Restaurants generally cannot determine the precise histamine content of a meal because histamine levels depend not only on the ingredients themselves but also on their freshness, processing, storage temperature, and the amount of time they were stored before preparation.

Choosing meals prepared from fresh, minimally processed ingredients may reduce potential exposure, but it cannot guarantee a low-histamine meal.

6. Protein powders are not automatically problematic

The amino acid histidine contained in dietary protein should not automatically be considered the problem simply because histamine can be synthesized from histidine.

Instead, tolerance to protein powders may depend on factors such as the protein source, processing, additives, flavorings, emulsifiers, preservatives, or other ingredients. Some components may potentially affect histamine release, histamine metabolism, or individual gastrointestinal tolerance.

Therefore, reactions to a particular protein supplement should not automatically be interpreted as evidence that protein or histidine itself is causing histamine intolerance.

An Important Finding

One of the article's most significant observations is its challenge to the widespread perception that histamine intolerance has become extremely common.

The article cites a placebo-controlled study involving 59 individuals who believed they had histamine intolerance. According to the reported findings:

  • only 4 participants (6.8%) demonstrated clear reactions to histamine but not placebo;

  • another 5 participants had inconclusive results;

  • 50 participants (84.7%) did not have confirmed histamine intolerance; and

  • almost 63% reacted to placebo.

The high placebo-response rate raises the possibility of a substantial nocebo effect, in which the expectation that a food or substance will cause symptoms can contribute to the perception or development of symptoms.

Importantly, a nocebo response does not mean that symptoms are fabricated or unreal. Rather, it illustrates how expectations and brain-body signaling can influence genuine symptom experiences and highlights why blinded testing and careful differential diagnosis are important.

Bottom Line

Current evidence suggests that histamine intolerance probably exists, but its true prevalence, underlying mechanisms, and diagnostic criteria remain uncertain. Estimates of approximately 1–3% prevalence have been proposed, but these figures should be interpreted cautiously because robust population-level diagnostic data are limited.

Many individuals who believe they have HIT may instead have another medical condition, overlapping food intolerance, gastrointestinal disorder, medication-related effect, allergy, or another explanation for their symptoms.

At present, there is no simple blood test, DAO measurement, or genetic test that can independently confirm histamine intolerance. Genetic analysis of AOC1 may indicate a potential predisposition toward altered DAO function, but predisposition is not equivalent to disease and should not be interpreted as diagnostic confirmation.

When HIT is suspected, the most evidence-based approach is a careful medical assessment, exclusion of alternative diagnoses, and a structured short-term elimination-and-rechallenge strategy, ideally conducted with appropriate medical or nutritional guidance.

At the same time, uncertainty surrounding the diagnosis should not lead clinicians to dismiss genuine symptoms. For individuals who do experience reproducible histamine-related reactions, the condition can have a meaningful impact on diet, daily activities, social life, and overall quality of life. The goal should therefore be to identify the most likely cause of symptoms while avoiding unnecessary dietary restriction or an unsupported diagnosis.

Reference: 

Histamine Intolerance—The More We Know the Less We Know. A Review 
https://www.mdpi.com/2072-6643/13/7/2228

DAO Deficiency, Histamine Intolerance, and Mast Cell Activation Syndrome (MCAS)
https://swaresearch.blogspot.com/2026/05/dao-deficiency-histamine-intolerance.html

DAO Deficiency, Histamine Intolerance, and Mast Cell Activation Syndrome (MCAS)
https://swaresearch.blogspot.com/2026/05/dao-deficiency-histamine-intolerance.html

Clearance mechanisms of the glymphatic/lymphatic system in the brain: new therapeutic perspectives for cognitive impairment
https://link.springer.com/article/10.1007/s11571-025-10298-y

Histamine Intolerance: Symptoms, Diagnosis, and Beyond
https://pmc.ncbi.nlm.nih.gov/articles/PMC11054089/

 

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right.
Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), a...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
Abstract Post-Polio Syndrome (PPS) develops in some survivors of paralytic poliomyelitis decades after recovery and is characterized by new or progressive muscle weakness, fatigue, pain, and reduced endurance. The prevailing pathophysiological model attributes PPS primarily to the gradual deterioration of enlarged motor units formed through compensatory axonal sprouting after the initial poliovirus (PV) infection. Although immune dysregulation and chronic systemic inflammation have been investigated as potential mechanisms, current evidence does not support classifying PPS as a primarily dysimmune or chronically inflammatory disorder. Nevertheless, the possible persistence of poliovirus-derived material and its biological significance remain subjects of investigation. Evidence for viral persistence has been reported in subsets of patients with PPS. In one study of 47 patients, elevated anti-poliovirus IgM antibodies were detected in some individuals, with titers reaching 1:250 compared...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Image
My Journey Toward Understanding Spinal Muscular Atrophy (SMA) Today, I better understand why Spinal Muscular Atrophy (SMA) received so little attention, particularly during the 1950s. This complex and debilitating genetic disorder was poorly understood, and patients’ symptoms could easily be minimized, misinterpreted, or dismissed. Even today, SMA can present significant diagnostic challenges, particularly in adults with complex medical histories. In my own experience, comprehensive investigations into the underlying cause of progressive muscle weakness were not always pursued. A Long and Complicated Diagnostic Journey In 2008, while being investigated for permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II .  I underwent surgery in 2009, but unfortunately, my symptoms did not improve. In 2010, a DNA test identified a genetic marker involving the ACTN3 gene . Further information about ACTN3 and its possible relation...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

By
Image
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening diseases that affect the skin and mucous membranes. They are usually caused by medications, especially antibiotics, antiepileptic drugs, and pain relievers, although infections can also trigger them. SJS involves less than 10% skin detachment, TEN involves more than 30%, and intermediate cases are called SJS/TEN overlap. A person with SJS often encounters primary care providers who have limited understanding of this life-threatening illness and may prescribe inappropriate medications.   The disease develops through a severe immune reaction in which cytotoxic T cells and natural killer cells attack keratinocytes, leading to widespread skin cell death. Several pathways are involved, including granzyme, Fas/FasL, perforin, and inflammatory cytokines such as TNF-α, IL-6, and IFN-γ. Genetic susceptibility also plays an important role, as certain HLA alleles are linked to higher risk in spe...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. A kidney transplant recipient with acute SARS-CoV-2 infection developed rhabdomyolysis and severe acute kidney injury (AKI) . A muscle biopsy confirmed findings consistent with immune-mediated necrotising myositis. Acid exposure and acid–base imbalances may profoundly affect the muscular and vascular systems. Strong acids from external sources, such as industrial chemicals, can cause corrosive tissue damage, while internal disturbances associated with metabolic disorders may disrupt cellular function and contribute to systemic complications. This article explores the potential effects of external acid exposure and internal acid–base disturbances on muscular and vascular health, including those associated with metabolic or genetic conditions. Because susceptibility to ME/CFS and complications following COVID-19 varies among individuals, further research may help determine whether genetic variant...
Read more

Impact of Penicillium on Muscle and Lung Function: What Healthcare Professionals Should Know

By
Image
Introduction While symbiotic relationships between viruses and bacteria have been documented, the possibility of a symbiosis between COVID-19 (SARS-CoV-2) and common fungal genera such as Penicillium , Aspergillus , and Trichoderma remains unexplored. This gap in research presents a potential area of interest for understanding novel microbial interactions and their implications for human health. Symbiosis Between Viruses and Bacteria – A Fascinating Partnership in the Microbial World https://swaresearch.blogspot.com/2025/07/symbiosis-between-viruses-and-bacteria.html When viruses, bacteria, or fungi—such as Penicillium —enter a host, they can trigger a range of immune responses and physiological disruptions.  Penicillium molds do not directly produce autoantibodies. However, exposure to Penicillium mold and its mycotoxins can trigger an immune response that may lead to the production of IgG antibodies , including those that could be reactive against the body's own tissues ,...
Read more